The Latest Breaking News from Vaccine

The World Health Organization says it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important step toward fighting against the disease in Africa and beyond

Early trial results show mRNA jab creates immune response against cancer

The jab, known as mRNA-4359, is developed by Moderna

Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

The globe is still getting over the catastrophic effects of the COVID-19 pandemic. Are we safe, nevertheless, still? There are also persistent worries about further epidemics. Experts from over the world are keeping a careful eye on changes as new diseases and strains keep popping up, especially at China's Wuhan…

African countries produce less than 2 percent of the vaccines the continent needs, experts say.

The US and Canada are in the middle of an opioid epidemic. But opioid use is a growing problem in other countries too.

Three children in far north Queensland have recently become unwell with meningococcal disease, a life-threatening infection caused by the bacteria Neisseria meningitidis.

Congo receives 50,000 JYNNEOS vaccine doses from the US and EU to combat monkeypox outbreak. Vaccination campaign to start in high-risk provinces.

Authorities in Congo say 50,000 doses of the mpox vaccine from the United States have arrived in the country